Clinical Trials Logo

Clinical Trial Summary

The study is designed to to assess the efficacy of ablative SBRT delivered with VMAT technique in oligometastatic patients affected by adrenal gland metastases.


Clinical Trial Description

This is a phase II, single arm, trial for testing efficacy of ablative high hypofractionated dose delivered with VMAT technique in oligometastatic patients with adrenal gland metastases. The potential advantages of this approach include the possibility to lead an increased local control in irradiated adrenal gland metastases. Other purpose of this study is to assess acute and late toxicity in terms of maintenance of endocrine mechanisms of hormonal production. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02848196
Study type Interventional
Source Istituto Clinico Humanitas
Contact
Status Active, not recruiting
Phase N/A
Start date October 19, 2016
Completion date January 2023

See also
  Status Clinical Trial Phase
Completed NCT01135238 - Adrenalectomy for Solitary Adrenal Gland Metastases N/A